ENTRY       D01369                      Drug
NAME        Bevantolol hydrochloride (JAN/USAN);
            Calvan (TN);
            Vantol (TN)
FORMULA     C20H27NO4. HCl
EXACT_MASS  381.1707
MOL_WEIGHT  381.8936
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG03180  alpha1 and beta-Adrenergic receptor antagonist
             DG03231  Antihypertensive
              DG03180  alpha1 and beta-Adrenergic receptor antagonist
REMARK      Therapeutic category: 2149
            ATC code: C07AB06
            Product: D01369<JP>
EFFICACY    Antiarrhythmic, Antihypertensive, Vasodilator, alpha1 and beta1-Adrenergic receptor antagonist, Calcium channel blocker
COMMENT     anti-anginal
TARGET      ADRB1 [HSA:153] [KO:K04141]
            ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
            CACNA1-L [HSA:775 776 778 779] [KO:K04850 K04851 K04853 K04857]
  PATHWAY   hsa04020(146+147+148+153+775+776+778+779)  Calcium signaling pathway
            hsa04080(146+147+148+153)  Neuroactive ligand-receptor interaction
            hsa04260(775+776+778+779)  Cardiac muscle contraction
            hsa04261(146+147+148+153+775+776+778+779)  Adrenergic signaling in cardiomyocytes
            hsa04270(146+147+148+775+776+778+779)  Vascular smooth muscle contraction
INTERACTION  
STR_MAP     map07214  beta-Adrenergic receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C07 BETA BLOCKING AGENTS
               C07A BETA BLOCKING AGENTS
                C07AB Beta blocking agents, selective
                 C07AB06 Bevantolol
                  D01369  Bevantolol hydrochloride (JAN/USAN) &lt;JP&gt;
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               214  Antihypertensives
                2149  Others
                 D01369  Bevantolol hydrochloride (JAN/USAN)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG03180  alpha1 and beta-Adrenergic receptor antagonist
                D01369  Bevantolol hydrochloride
              DG03231  Antihypertensive
               DG03180  alpha1 and beta-Adrenergic receptor antagonist
                D01369  Bevantolol hydrochloride
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D01369  Bevantolol hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D01369  Bevantolol hydrochloride (JAN/USAN) &lt;JP&gt;
                ADRB1
                 D01369  Bevantolol hydrochloride (JAN/USAN) &lt;JP&gt;
             Ion channels
              Voltage-gated ion channels
               Calcium channels
                CACNA1-L
                 D01369  Bevantolol hydrochloride (JAN/USAN) &lt;JP&gt;
DBLINKS     CAS: 42864-78-8
            PubChem: 7848432
            ChEBI: 31282
            LigandBox: D01369
            NIKKAJI: J521.603F
ATOM        26
            1   O2a O    14.4598  -16.6293
            2   C1b C    15.6476  -15.9306
            3   C1c C    16.8355  -16.6293
            4   C1b C    18.0932  -15.9306
            5   O1a O    16.8355  -18.0267
            6   N1b N    19.2810  -16.6293
            7   C1b C    20.4688  -15.9306
            8   C1b C    21.7265  -16.6293
            9   C8y C    22.9144  -15.9306
            10  C8x C    22.9144  -14.5331
            11  C8x C    24.1022  -13.8344
            12  C8y C    25.2900  -14.5331
            13  C8y C    25.2900  -15.9306
            14  C8x C    24.1022  -16.6293
            15  O2a O    26.5478  -13.8344
            16  C1a C    27.7356  -14.5331
            17  O2a O    26.5478  -16.6293
            18  C1a C    27.7356  -15.9306
            19  C8y C    14.4598  -18.0293
            20  C8x C    13.2574  -18.7239
            21  C8y C    13.2578  -20.1239
            22  C8x C    14.4704  -20.8236
            23  C8x C    15.6728  -20.1290
            24  C8x C    15.6724  -18.7290
            25  C1a C    12.0401  -20.8276
            26  X   Cl   24.9306  -20.2698
BOND        26
            1     6   7 1
            2     7   8 1
            3     8   9 1
            4     1   2 1
            5     2   3 1
            6     9  10 2
            7    10  11 1
            8    11  12 2
            9    12  13 1
            10   13  14 2
            11   14   9 1
            12    3   4 1
            13   12  15 1
            14   15  16 1
            15    3   5 1
            16   13  17 1
            17   17  18 1
            18    4   6 1
            19    1  19 1
            20   19  20 2
            21   20  21 1
            22   21  22 2
            23   22  23 1
            24   23  24 2
            25   19  24 1
            26   21  25 1
///
